KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $1.2 billion.

  • Incyte's Operating Expenses rose 3349.25% to $1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 billion, marking a year-over-year decrease of 1324.13%. This contributed to the annual value of $3.6 billion for FY2025, which is 1324.13% down from last year.
  • As of Q4 2025, Incyte's Operating Expenses stood at $1.2 billion, which was up 3349.25% from $922.5 million recorded in Q3 2025.
  • In the past 5 years, Incyte's Operating Expenses registered a high of $1.5 billion during Q2 2024, and its lowest value of $505.9 million during Q1 2021.
  • In the last 5 years, Incyte's Operating Expenses had a median value of $772.4 million in 2023 and averaged $804.9 million.
  • As far as peak fluctuations go, Incyte's Operating Expenses plummeted by 5895.2% in 2021, and later skyrocketed by 10003.01% in 2024.
  • Incyte's Operating Expenses (Quarter) stood at $752.1 million in 2021, then increased by 13.89% to $856.6 million in 2022, then dropped by 3.56% to $826.1 million in 2023, then increased by 6.19% to $877.2 million in 2024, then skyrocketed by 33.49% to $1.2 billion in 2025.
  • Its Operating Expenses stands at $1.2 billion for Q4 2025, versus $922.5 million for Q3 2025 and $685.2 million for Q2 2025.